| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8534537 | Life Sciences | 2018 | 42 Pages |
Abstract
Our data demonstrate that PDTC ameliorates diclofenac-induced AKI and that targeting NF-κB signaling pathway is a promising therapeutic approach for the treatment of diclofenac-induced AKI.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sergio M. Borghi, Victor Fattori, Kenji W. Ruiz-Miyazawa, Mariana M. Bertozzi, Yuri Lourenco-Gonzalez, Roberto I. Tatakihara, Allan J.C. Bussmann, Tânia L. Mazzuco, Rubia Casagrande, Waldiceu A. Jr,